JOHNSON & JOHNSON Annual Deferred Income Tax Expense (Benefit) in USD from 2009 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Johnson & Johnson quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2009 to 2023.
- Johnson & Johnson Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$1.56B, a 1.23% decline year-over-year.
- Johnson & Johnson annual Deferred Income Tax Expense (Benefit) for 2023 was -$4.19B, a 152% decline from 2022.
- Johnson & Johnson annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.66B, a 20% increase from 2021.
- Johnson & Johnson annual Deferred Income Tax Expense (Benefit) for 2021 was -$2.08B, a 82.2% decline from 2020.
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)